Up

Modified August 31, 2011

Publications of Classen Immunotherapies, Inc.

Classen, J.B.: U.S. patent application 08/104,529, 1993. Method and composition for an early vaccine to protect against both infectious diseases and chronic immune mediated disorders or their sequela.

 

Classen, J.B.: PCT international patent application, PCT/US94/08825, 1994. Method and composition for an early vaccine to protect against both infectious diseases and chronic immune mediated disorders or their sequela.

 

Classen, J.B.: U.S. patent application 08/450,586. Method and composition for an early vaccine to protect against both infectious diseases and chronic immune mediated disorders or their sequela.

 

Classen, J.B., and Classen, D.C.: Vaccines modulate type I diabetes. Diabetologia 39: 500- 501, 1996.

 

Classen, J.B.: Diabetes epidemic follows hepatitis B immunization program. New Zealand Medical Journal, 109: 195, 1996.

 

Classen, J.B.: The timing of immunization affects the development of diabetes in rodents. Autoimmunity, 24: 137-145, 1996 .

 

Classen, J.B., and Classen, D.C.: Timing of immunization alters risk of diabetes. ICAAC Abstract: 1996.

 

Classen, J.B.: The diabetes epidemic and the hepatitis B vaccine. New Zealand Medical Journal, 109: 366, 1996.

 

Classen, D.C. and Classen, J.B.: The timing of pediatric immunization and the risk of insulin- dependent diabetes. Infectious Diseases in Clinical Practice, 6: 449-454, 1997.

 

Classen, J.B., and Classen, D.C.: Incidence of IDDM in Germany is not higher than predicted. Diabetes Care, 20(11), 1799-1800, 1997.

 

Classen, J.B. : Trials without placebo controls in pre-IDDM: is there an advantage?
Diabetes Metab Rev. 1997 Dec; 13(4): 317

 

Classen, J.B.: U.S. patent 5,723,283. Method and composition for an early vaccine to protect against both infectious diseases and chronic immune mediated disorders or their sequela.

 

Classen, J.B.: U.S. patent 5,728,385. Method and composition for an early vaccine to protect against both infectious diseases and chronic immune mediated disorders or their sequela.

 

Classen, J.B., Cyclosporine induce autoimmunity in newborns prevented by early immunization. Autoimmunity, 27(3): 135-139, 1998.

 

Classen, J.B., and Classen, D.C.: Public should be told that vaccines may have adverse effects. British Medical Journal, 318:193, 1999.

 

Classen, J.B., and Classen, D.C.:Hemophilus vaccine and increased IDDM, causal relationship likely. eBMJ, May 7, 1999   http://www.bmj.com/cgi/eletters/318/7192/1169

 

Classen, J.B., and Classen, D.C.: Vaccines, autoimmune diabetes (IDDM), and accountability. British Medical Journal, 318:1487, 1999.

 

Classen, J.B., and Classen, D.C.: Immunization in the first month of life may explain decline in incidence of IDDM in the Netherlands. Autoimmunity, 31:43-45, 1999.

 

Classen, J.B., and Classen, D.C.: Vertically transmitted enteroviruses and the benefits of neonatal immunization. Diabetes Care 22 (10): 1760, 1999.

 

Classen, J.B., and Classen, D.C.: Association between type 1 diabetes and Hib vaccine, causal relation likely. British Medical Journal, 319:1133, 1999.

 

Classen, J.B., and Classen, D.C.: Immunisation and type 1 diabetes mellitus: is there a link? Drug Safety 21(5):423-5, 1999.

 

Classen, J.B., and Classen, D.C.: Hemophilus vaccine associated with increased risk of diabetes, causality likely. Diabetes Care 23: 872, 2000.

 

Paolo Pozzilli, Natalia Visalli, Guisy Coppolino, David Carey Classen, John B. Classen and the IMDIAB Group: Hepatitis B Vaccine Associated with an Increased Risk of Type 1 Diabetes in Italy. Abstract 272, 60th Scientific Session, American Diabetes Association Meeting, San Antonio, Texas: June 13, 2000.

 

Classen, J.B., and Classen, D.C.: Vaccines and the risk of insulin- dependent diabetes (IDDM): potential mechanisms of action. Medical Hypotheses 57:532-538, 2001.

 

Classen, J.B., and Classen, D.C.: The safety of military immunization and the risk of insulin dependent diabetes. Clinical Practice of Alternative Medicine 2:247-252, 2001.

 

Classen, J.B., and Classen, D.C.: Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after Hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM. Autoimmunity 35:247-253,2002.

 

Classen, J.B., and Classen, D.C.: Clustering of cases of IDDM occurring 2-4 years after vaccination is consistent with clustering after infections and progression to IDDM in autoantibody positive individuals. Journal of Pediatric Endocrinology and Metabolism   16 (4):495-507; 2003.

 

Classen, J.B.: Pertussis infections, vaccines  and type 1 diabetes. Diabetic Medicine. 21(4):397-8, 2004.

 

Classen, J.B.: Enhanced funding of pharmacoepidemiology through patenting the disclosure of adverse event information. Pharmacoepidemiology and Drug Safety 15:390-393, 2006.

 

Classen, J.B.: Clustering of Cases of IDDM 2 to 4 Years after Hepatitis B Immunization is Consistent with Clustering after Infections and Progression to IDDM in Autoantibody Positive Individuals. The Open Pediatric Medicine Journal  2: 1-6, 2008.

 

Classen, J.B.: Risk of Vaccine Induced Diabetes in Children with a Family History of Type 1 Diabetes. The Open Pediatric Medicine Journal  2: 7-10, 2008.

 

Classen, J.B.: Discontinuation of BCG Vaccination Precedes Significant Drop in Type 2 Diabetes in Japanese Children. Role of Inflammation and Cortisol Activity as a Cause of Type 2 Diabetes The Open Endocrinology Journal  2: 1-4, 2008.

 

Classen, J.B.: Type 1 Diabetes Versus Type 2 Diabetes/Metabolic Syndrome, Opposite Extremes of an Immune Spectrum Disorder Induced by Vaccines The Open Endocrinology Journal 2: 9-15, 2008.

 

Classen, J.B.: Evidence childhood epidemics of type 1 and type 2 diabetes are opposite extremes of an immune spectrum disorder induced by immune stimulants. Role of race and associated cortisol activity as a major determining factor of the type of diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 3: 67-69, 2009.

 

Classen, J.B.: More evidence that epidemics of Type  1 and Type 2 diabetes/metabolic syndrome are polar opposite responses (ie symptoms) to a primary inflammatory disease. Abstract  2651-PO, 70th Scientific Session, American Diabetes Association Meeting, 2010.

 

Classen, J.B.: Italian Pediatric Data Support Hypothesis that Simultaneous Epidemics  of Type  1 Diabetes and Type 2 Diabetes/Metabolic Syndrome/Obesity are Polar Opposite Responses (ie symptoms) to a Primary Inflammatory Condition. Journal of Pediatric Endocrinology and Metabolism 24 (7-8): 455-456, 2011.